Stock screenerAll disclosures →
EDGAR →
LGVN
Conviction 20HealthcareScan · Mon, Aug 10, 2026LGVN$0.7205-5.94%
ResistanceSupportVol 14Vol MA14 288.33K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.7205
Change-5.94%
Gap+0.52%
Rel volume0.43×
Avg volume249.36K
Avg $ vol170.86K
SMA 200.6593
SMA 500.7077
SMA 2000.7260
Price vs 50+1.80%
Price vs 200-0.76%
MA stackmixed
50/200 cross—
Supertrendup · 0.6092
RSI (14)55
MACD hist0.02
MACD cross—
Stoch %K / %D65 / 79
ADX (14)26
+DI / −DI25 / 14
RSI divergenceBullish
MACD divergenceBullish
ATR %+7.79%
ADR %7.18%
52w high1.16
52w low0.4836
From 52w high-37.89%
Above 52w low+48.99%
New 52w highNo
SqueezeOff
Bollinger width37.17%
%B0.75
Donchian pos64.65%
Donchian high0.8000
Donchian low0.5751
AVWAP (52w high)0.8669
vs AVWAP high-16.89%
AVWAP (52w low)0.8977
vs AVWAP low-19.74%
OBV trendUp
Chaikin MF (20)-0.31
Today vs 20d0.43×
Avg vol (14d)288.33K
Avg vol (20d)249.36K
Avg $ vol (20d)170.86K
Market cap12.66B
RS 3m (vs SPY)-15.77%
RS 6m (vs SPY)+35.79%
RS line new highNo
Trend template3/8
Technical rank63.0
1 week-1.57%
1 month+6.74%
3 months-14.75%
6 months+40.45%
1 year-43.27%
YTD+21.50%
P/E-557.78
P/B790.16
P/S—
P/FCF-670.40
EPS-1.29
Div yield—
ROE-141.66%
ROA-107.04%
Debt/Eq0.01
Current3.88
EV/EBITDA-562.47
Gross margin66.97%
Net margin—
Rev growth-49.87%
EPS growth-42.14%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value12.65B
Revenue398K
Net income-4.74M
Gross profit264K
Free cash flow-18.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out30.15M
Employees38
ListedFri, Feb 12, 2021
Free float19.66M
Float %90.3%
Short interest1.53M
Days to cover4.8d
Short volume60.3%
Squeeze score53 / 100
Next earningsWed, Aug 12, 2026 · after (2d)
EPS forecast−$0.19 · 3 est
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank63.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.8325
Support0.5806
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LGVN
No recent disclosed trades by Congress in LGVN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in LGVN · 7 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hare Joshua Chief Scientific Officer · Class B Common Stock · 2026-07-06 | Grant | 600K | — | 2026-07-06 | 2026-07-08 |
Hare Joshua Chief Scientific Officer · Stock Option (right to buy) · 2026-07-06 | Grant | 400K | — | 2026-07-06 | 2026-07-08 |
Agafonova Nataliya Chief Medical Officer · Class A Common Stock · 2026-07-01 | Tax | 22.5K | $16K | 2026-07-01 | 2026-07-06 |
Blass Devin CTO & SVP of CMC · Class A Common Stock · 2026-05-01 | Grant | 250K | $0 | 2026-05-01 | 2026-05-05 |
Agafonova Nataliya Chief Medical Officer · Class A Common Stock · 2026-05-01 | Grant | 250K | $0 | 2026-05-01 | 2026-05-05 |
Locklear Lisa Chief Financial Officer · Class A Common Stock · 2026-05-01 | Grant | 250K | $0 | 2026-05-01 | 2026-05-05 |
Willard Stephen H Chief Executive Officer · Class A Common Stock · 2026-05-01 | Grant | 500K | $0 | 2026-05-01 | 2026-05-05 |
Lehr Paul T General Counsel, Secretary · Class A Common Stock · 2026-05-01 | Grant | 250K | $0 | 2026-05-01 | 2026-05-05 |
SEC filings
EDGAR filings in LGVN · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.